Last Updated on 2 years by Publishing Team
Transmission Update: Since the last update, we have recorded a total of 39 new cases; of which 22 new cases were recorded on 30/10/2021, 8 new cases on 31/10/2021, and 9 new cases in the last 24 hours ending at 8 am this morning.This epidemic curve depicts the daily positive cases since the 2nd wave of this outbreak began in April 2021. Overall for this 2nd wave, there have been 52,110 cases recorded, with 71% of the cases from the Central Division, 28% of the cases from the Western Division, and 1% of the cases from the Eastern and Northern Division. Our National 7- day rolling average is 23 daily cases calculated for 28th October 2021. |
Deaths: We do not have any COVID-19 deaths to report.
There have been 674 deaths due to COVID-19 in Fiji, with 672 of these deaths during the outbreak that started in April this year. Please note that due to the time required by clinical teams to investigate, classify and report deaths, a 4-day interval is given to calculate the 7 days rolling average of deaths, based on the date of death, to help ensure the data collected is complete before the average is reported. Therefore, as of October 27th, the national 7 days rolling average of COVID-19 deaths per day is 0.3. The 7 days rolling average for COVID-19 deaths per day in the Central Division is 0.3 and 0.0 in the Western Division. The case fatality rate for COVID-19 deaths in Fiji is 1.29%. We have also recorded 566 COVID-19 positive patients who died from the serious medical conditions they had before they contracted COVID-19; these are not classified as COVID-19 deaths. |
Epidemic Outlook:
The Ministry of Health continues to monitor the outbreak using indicators such as daily case numbers, hospitalizations, test positivity, and deaths. There is a downward trend across all indicators of the COVID-19 epidemic in Fiji, indicating a positive response to our overall COVID containment and mitigation response.
Occupancy rates in health facilities, the occupancy rate of ICU beds, death rates, and vaccination coverage are indicators to monitor our health response capacity and we see a decreasing trend across indicators from our health facilities with increasing vaccination coverage for adults and 15-17-year-olds in Fiji.
Our weekly testing numbers of over 7,000 are still above the WHO recommended rate of 4 tests per 1,000 population per week (or approx. 3,500 tests per week) and we anticipate continued surveillance and testing in our communities and maritime islands to monitor and detect cases for early intervention.
Public Advisory:
A disease becomes endemic when it is expected to remain persistently present in the community. Some diseases endemic to Fiji are dengue fever and the common cold. These diseases persist at some level in the community and become epidemic when levels go beyond what is determined to be expected and acceptable. Determining what that acceptable level of disease is for COVID-19, is a work in progress but in general, it will be at the level which triggers additional control measures, Because COVID-19 is a vaccine-preventable disease, and the vaccines are very good at preventing severe disease and death, in a highly vaccinated population determining and monitoring acceptable levels, or thresholds, goes beyond case numbers. A disease that causes frequent cases in the community (like the common cold) but has a small impact on the numbers of people needing hospitalization or death, and minimal impact on the health system, will require less intervention. This is why we will be closely monitoring the following indicators: cases, test positivity, hospitalisations, and deaths.
Unfortunately, vaccine-related herd protection is not likely to be as efficient with COVID 19 as seen with some of the traditional vaccine-related diseases like measles. Recent data verified and released by the CDC indicate that unvaccinated people with the previous COVID 19 infection were 5 times more likely to have a positive covid 19 test compared to vaccinated people. As such unvaccinated people cannot rely on herd immunity (or herd protection) nor natural immunity to protect themselves. Those eligible must get vaccinated to reduce their risk of infection, severe disease, and death. And we know vaccines are very good in preventing severe disease and deaths.
This lower efficiency in vaccine-related herd immunity also means that the public will need to live with COVID safe measures of masking, hand washing, physical distancing, and good ventilation and/or air cleaning technology. These COVID safe measures remain vital in preventing the need to go back to severely restrictive public health measures.
Supporting School Re-opening
COVID-19 poses a lower risk to children however secondary transmission from young school-age children can and does occur in both household and school settings. Our vaccine deployment program for children aged 15 to 17 years is going well and we are planning on initiating Pfizer Vaccine deployment from the 15th of November for children aged 12 to 15 years. Conditions required to facilitate COVID safe school conditions have been discussed with the Ministry of Education and a training program to create awareness around COVID safe school conditions has been facilitated for senior education officials.
We note the recent news that the FDA has issued emergency approval for Pfizer to be given to children aged 5 to 11 years, with a pediatric dose of one-third that is given to adults and adolescents. This pediatric dose is given as two shots three weeks apart and is considered by the FDA to be safe and 90% effective.
Travel to the North
For the North, the Ministry of Health and Medical Services is supporting a repatriation program and not a social travel program. As such travel for short-term goals is likely to be adversely affected if a person turns out positive while in quarantine. We are doing all we can to improve vaccination coverage in the North and we will review these quarantine measures for local travel after the 11th of November.